Literature DB >> 17076993

What to inject when oral agents fail?

Anthony L McCall.   

Abstract

Year:  2006        PMID： 17076993     DOI： 10.1007/s11892-006-0003-1

Source DB:  PubMed          Journal:  Curr Diab Rep        ISSN： 1534-4827            Impact factor:   4.810


× No keyword cloud information.
  9 in total

1.  Treatment of type 2 diabetes mellitus: a weighty enigma.

Authors:  Richard J Comi
Journal:  Ann Intern Med       Date:  2005-10-18       Impact factor: 25.391

2.  Relationships between hyperglycemia and cognitive performance among adults with type 1 and type 2 diabetes.

Authors:  Daniel J Cox; Boris P Kovatchev; Linda A Gonder-Frederick; Kent H Summers; Anthony McCall; Kevin J Grimm; William L Clarke
Journal:  Diabetes Care       Date:  2005-01       Impact factor: 19.112

3.  Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). UK Prospective Diabetes Study (UKPDS) Group.

Authors:  R C Turner; C A Cull; V Frighi; R R Holman
Journal:  JAMA       Date:  1999-06-02       Impact factor: 56.272

4.  Effects of exenatide (exendin-4) on glycemic control over 30 weeks in sulfonylurea-treated patients with type 2 diabetes.

Authors:  John B Buse; Robert R Henry; Jenny Han; Dennis D Kim; Mark S Fineman; Alain D Baron
Journal:  Diabetes Care       Date:  2004-11       Impact factor: 19.112

5.  Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes.

Authors:  Louis Monnier; Emilie Mas; Christine Ginet; Françoise Michel; Laetitia Villon; Jean-Paul Cristol; Claude Colette
Journal:  JAMA       Date:  2006-04-12       Impact factor: 56.272

6.  Effects of exenatide (exendin-4) on glycemic control and weight over 30 weeks in metformin-treated patients with type 2 diabetes.

Authors:  Ralph A DeFronzo; Robert E Ratner; Jenny Han; Dennis D Kim; Mark S Fineman; Alain D Baron
Journal:  Diabetes Care       Date:  2005-05       Impact factor: 19.112

7.  Effects of exenatide (exendin-4) on glycemic control over 30 weeks in patients with type 2 diabetes treated with metformin and a sulfonylurea.

Authors:  David M Kendall; Matthew C Riddle; Julio Rosenstock; Dongliang Zhuang; Dennis D Kim; Mark S Fineman; Alain D Baron
Journal:  Diabetes Care       Date:  2005-05       Impact factor: 19.112

Review 8.  Enhancing incretin action for the treatment of type 2 diabetes.

Authors:  Daniel J Drucker
Journal:  Diabetes Care       Date:  2003-10       Impact factor: 19.112

9.  The treat-to-target trial: randomized addition of glargine or human NPH insulin to oral therapy of type 2 diabetic patients.

Authors:  Matthew C Riddle; Julio Rosenstock; John Gerich
Journal:  Diabetes Care       Date:  2003-11       Impact factor: 19.112
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.